Cipla, a global pharmaceutical company, says it has developed a first-of-its-kind Indian anti-aging skincare product that uses human bio-active factors. The product is Cutisera, developed by Stempeutics.

Cutisera claims to deliver 5 benefits, according to the company, including: reducing fine lines and wrinkles; lightening dark spots; evening skin tone; improving skin firmness; and improving skin hydration.

It is packaged in an airless pack that ensures its effectiveness throughout its period of use. The ingredients are stable for eighteen months under cool and dry conditions.

Chandru Chawla, head of Cipla New Ventures, said, “We are excited to launch Cutisera – the next generation bio-engineered skin care product. As we age and get exposed to environmental stressors, the production of human growth factors within skin is depleted, giving rise to features of ageing skin. By re-introducing these factors through daily application of Cutisera, damaged skin cells are repaired resulting in rejuvenation of the skin.”

BN Manohar, CEO of Stempeutics, added, “We are pleased to market Cutisera through our JV partner Cipla. Already physician and consumer interest in Cutisera has been high. Cutisera has been developed using a unique and proprietary patent-pending technology that produces stable key ingredients containing growth factors and cytokines in specified amounts – batch after batch. This results in a consistent high quality product bench marked globally.”